• Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Smspharma Share Price

    Sms Pharmaceuticals Share PriceSMS Pharmaceuticals

    Small Cap 16.2k Result
    ₹118.4
    -0.6 (-0.5%)
    As on 01 December, 2023 | 02:09 BSE: 532815 NSE: SMSPHARMAISIN: INE812G01025

    Sms Pharmaceuticals Performance

    Day Range

    • Low 117.20
    • High 119.85
    ₹ 118.4

    52 Week Range

    • Low 54.55
    • High 140.00
    ₹ 118.4
    • Open Price119.05
    • Previous Close119.00
    • Volume66901

    Start SIP in SMS Pharmaceuticals

    Start SIP

    Sms Pharmaceuticals Share Price

    • Over 1 Month 1.15%
    • Over 3 Month -8.15%
    • Over 6 Month 42.48%
    • Over 1 Year 38.48%

    Sms Pharmaceuticals Key Statistics

    P/E Ratio 32.3
    PEG Ratio 0
    Market Cap Cr 1,002
    Price to Book Ratio 2.2
    EPS 0.5
    Dividend 0.3
    Relative Strength Index 46.84
    Money Flow Index 55.28
    MACD Signal -0.36
    Average True Range 3.82

    Sms Pharmaceuticals Investment Rating

    • Master Rating:

    • Sms Pharmaceuticals has an operating revenue of Rs. 600.21 Cr. on a trailing 12-month basis. An annual revenue de-growth of 0% needs improvement, Pre-tax margin of 1% needs improvement, ROE of -1% is poor and needs improvement. The company has a reasonable debt to equity of 26%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 20% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 15% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 69 which is a FAIR score but needs to improve its earnings, a RS Rating of 62 which is FAIR indicating the recent price performance, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 69 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock definitely has some strength, you may want to examine it in more detail.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    SMS Pharmaceuticals Financials
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 1671351491491596461
    Operating Expenses Qtr Cr 1391091261311466565
    Operating Profit Qtr Cr 28272318140-4
    Depreciation Qtr Cr 8888888
    Interest Qtr Cr 6666554
    Tax Qtr Cr 34310-3-25
    Net Profit Qtr Cr 129851-109
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 527525
    Operating Expenses Annual Cr 467405
    Operating Profit Annual in Cr 55114
    Depreciation Cr 3232
    Interest Annual Cr 2219
    Tax Annual Cr 11
    Net Profit Annual Cr 468
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 2240
    Cash from Investing Activity Annual Cr -30-27
    Cash from Financing Annual Activity Cr -32-7
    Net Cash Flow Annual Cr -396
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 495494
    Fixed Assets Annual Cr 445449
    Total Non Current Assets Annual Cr 504506
    Total Current Assets Annual Cr 411377
    Total Assets Annual Cr 914883
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 5858
    ROE Annual % 114
    ROCE Annual % 413
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1123
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 1671351491491596461
    Operating Expenses Qtr Cr 1391091261301466565
    Operating Profit Qtr Cr 2826231914-1-4
    Depreciation Qtr Cr 8888888
    Interest Qtr Cr 6666554
    Tax Qtr Cr 34310-3-25
    Net Profit Qtr Cr 12964-2-136
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 527525
    Operating Expenses Annual Cr 468406
    Operating Profit Annual in Cr 55114
    Depreciation Cr 3232
    Interest Annual Cr 2219
    Tax Annual Cr 11
    Net Profit Annual Cr -762
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 2240
    Cash from Investing Activity Annual Cr -30-27
    Cash from Financing Annual Activity Cr -32-7
    Net Cash Flow Annual Cr -396
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 461470
    Fixed Assets Annual Cr 445449
    Total Non Current Assets Annual Cr 469482
    Total Current Assets Annual Cr 411377
    Total Assets Annual Cr 880860
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 5456
    ROE Annual % -213
    ROCE Annual % 413
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1123
    Invest in Sms Pharmaceuticals

    Sms Pharmaceuticals Technicals

    EMA & SMA

    Current Price
    ₹118.4
    -0.6 (-0.5%)
    pointer
    • Bullish Moving Average
    • ___
    • 4
    • Bearish Moving Average
    • ___
    • 12
    • 20 Day
    • ₹119.44
    • 50 Day
    • ₹119.65
    • 100 Day
    • ₹115.56
    • 200 Day
    • ₹107.09
    • 20 Day
    • ₹119.46
    • 50 Day
    • ₹120.47
    • 100 Day
    • ₹119.90
    • 200 Day
    • ₹99.25

    Sms Pharmaceuticals Resistance and Support

    PIVOT
    ₹118.49
    Resistance
    First Resistance 119.77
    Second Resistance 121.13
    Third Resistance 122.42
    RSI 46.84
    MFI 55.28
    MACD Single Line -0.36
    MACD -0.21
    Support
    First Resistance 117.12
    Second Resistance 115.83
    Third Resistance 114.47

    Sms Pharmaceuticals Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 78,908 4,680,823 59.32
    Week 195,937 11,123,358 56.77
    1 Month 148,390 7,630,194 51.42
    6 Month 172,895 8,113,956 46.93

    Sms Pharmaceuticals Result Highlights

    SMS Pharmaceuticals Synopsis

    NSE-Medical-Generic Drugs

    Sms Pharmaceuticals is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 522.05 Cr. and Equity Capital is Rs. 8.47 Cr. for the Year ended 31/03/2023. SMS Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 14/12/1987 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L24239TG1987PLC008066 and registration number is 008066.
    Market Cap 1,002
    Sales 600
    Shares in Float 3.05
    No of funds 4
    Yield 0.25
    Book Value 2.03
    U/D Vol ratio 2
    LTDebt / Equity 24
    Alpha 0.12
    Beta 0.78

    SMS Pharmaceuticals

    Owner NameSep-23Jun-23Mar-23Dec-22
    Promoters 64.32%64.32%64.29%64.17%
    Mutual Funds
    Foreign Portfolio Investors 0.6%0.67%0.59%0.59%
    Individual Investors 29.07%29.04%29.01%28.82%
    Others 6.01%5.97%6.11%6.42%

    SMS Pharmaceuticals Management

    Name Designation
    Mr. Ramesh Babu Potluri Chairman & Managing Director
    Mr. Vamsi Krishna Potluri Executive Director
    Mr. Sarath Kumar Pakalapati Independent Director
    Mr. Sharvan Kudaravalli Independent Director
    Mr. Sarvepalli Srinivas Independent Director
    Dr.(Mrs.) Neelaveni Thummala Independent Director

    Sms Pharmaceuticals Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Sms Pharmaceuticals Corporate Action

    Date Purpose Remarks
    2023-11-08 Quarterly Results
    2023-08-08 Quarterly Results
    2023-05-24 Audited Results & Final Dividend
    2023-02-09 Quarterly Results
    2022-11-12 Quarterly Results
    Date Purpose Remarks
    2023-09-22 FINAL Rs.0.30 per share(30%)Final Dividend
    2022-09-23 FINAL Rs.0.30 per share(30%)Final Dividend

    SMS Pharmaceuticals MF Shareholding

    Name Amount(cr)
    Motilal Oswal S&P BSE Healthcare ETF 8

    SMS Pharmaceuticals FAQs

    What is Share Price of SMS Pharmaceuticals ?

    SMS Pharmaceuticals share price is ₹118 As on 01 December, 2023 | 01:55

    What is the Market Cap of SMS Pharmaceuticals ?

    The Market Cap of SMS Pharmaceuticals is ₹1002.3 Cr As on 01 December, 2023 | 01:55

    What is the P/E ratio of SMS Pharmaceuticals ?

    The P/E ratio of SMS Pharmaceuticals is 32.3 As on 01 December, 2023 | 01:55

    What is the PB ratio of SMS Pharmaceuticals ?

    The PB ratio of SMS Pharmaceuticals is 2.2 As on 01 December, 2023 | 01:55

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.